SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-061151
Filing Date
2024-07-15
Accepted
2024-07-15 06:04:39
Documents
15
Period of Report
2024-07-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0209387-8k_onconetix.htm   iXBRL 8-K 24805
2 PRESS RELEASE, DATED JULY 15, 2024 ea020938701ex99-1_onconetix.htm EX-99.1 10684
3 GRAPHIC e99-1_001.jpg GRAPHIC 2721
  Complete submission text file 0001213900-24-061151.txt   217694

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE onco-20240715.xsd EX-101.SCH 3042
5 XBRL LABEL FILE onco-20240715_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE onco-20240715_pre.xml EX-101.PRE 22377
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0209387-8k_onconetix_htm.xml XML 3681
Mailing Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202
Business Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202 513-620-4101
Onconetix, Inc. (Filer) CIK: 0001782107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41294 | Film No.: 241115782
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)